OMER FDA approved drug

Omeros Corp Wainwright raised its price target to $40 following its approval of drug Yartemlea by the FDA. Partnering with Novo Nordisk on another treatment. Launch is scheduled for “January” believed to be last week of January and should be a catalyst to lift this into the $20s at least Worth a look. Good luck!